Latest / Durham News Today | 2 Min News | The Daily News Now!
Pelosi's Tempus AI Bet Holds Up | Durham News
Nancy Pelosi’s investment in Tempus AI, a healthcare tech giant with a buzzy stock, is under fresh scrutiny as the company posts strong Q2 earnings and eyes major growth catalysts — including FDA approval for a cancer test set to boost revenue in 2027 and a strategic acquisition — even as debt and short-term losses temper the outlook. Analysts remain bullish, calling it a buy or hold, though its current valuation may limit quick gains. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.